Sanne Hoeks

General Discussion 119 7 47. Cohen IR, Efroni S. The Immune System Computes the State of the Body: Crowd Wisdom, Machine Learning, and Immune Cell Reference Repertoires Help Manage Inflammation. Front Immunol . 2019;10:10. doi:10.3389/ fimmu.2019.00010 48. Jolles JW, Boogert NJ, Sridhar VH, Couzin ID, Manica A. Consistent Individual Differences Drive Collective Behavior and Group Functioning of Schooling Fish. Curr Biol . Sep 2017;27(18):2862-2868.e7. doi:10.1016/j.cub.2017.08.004 49. Nobile M. THE WHO DEFINITION OF HEALTH: A CRITICAL READING. Med Law . Jul 2014;33(2):33-40. 50. Laforest-Lapointe I, Arrieta MC. Patterns of Early-Life Gut Microbial Colonization during Human Immune Development: An Ecological Perspective. Front Immunol . 2017;8:788. doi:10.3389/fimmu.2017.00788 51. Vatanen T, Kostic AD, d’Hennezel E, et al. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell . May 2016;165(4):842-53. doi:10.1016/j.cell.2016.04.007 52. Brodin P, Jojic V, Gao T, et al. Variation in the human immune system is largely driven by non-heritable influences. Cell . Jan 2015;160(1-2):37-47. doi:10.1016/j.cell.2014.12.020 53. Orrù V, Steri M, Sole G, et al. Genetic variants regulating immune cell levels in health and disease. Cell . Sep 2013;155(1):242-56. doi:10.1016/j.cell.2013.08.041 54. Patin E, Hasan M, Bergstedt J, et al. Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors. Nat Immunol . 03 2018;19(3):302-314. doi:10.1038/s41590-018-0049-7 55. Roederer M, Quaye L, Mangino M, et al. The genetic architecture of the human immune system: a bioresource for autoimmunity and disease pathogenesis. Cell . Apr 2015;161(2):387-403. doi:10.1016/j.cell.2015.02.046 56. Kaczorowski KJ, Shekhar K, Nkulikiyimfura D, et al. Continuous immunotypes describe human immune variation and predict diverse responses. Proc Natl Acad Sci U S A . 07 2017;114(30):E6097-E6106. doi:10.1073/pnas.1705065114 57. Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev . Aug 2005;14(8):1847-50. doi:10.1158/1055-9965.EPI-05-0456 58. Kabat AM, Srinivasan N, Maloy KJ. Modulation of immune development and function by intestinal microbiota. Trends Immunol . Nov 2014;35(11):507-17. doi:10.1016/j.it.2014.07.010 59. Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science . Apr 2016;352(6285):539-44. doi:10.1126/science.aad9378 60. Gasparrini AJ, Wang B, Sun X, et al. Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome. Nat Microbiol . 12 2019;4(12):2285-2297. doi:10.1038/s41564- 019-0550-2 61. Tapiainen T, Koivusaari P, Brinkac L, et al. Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants. Sci Rep . 07 2019;9(1):10635. doi:10.1038/s41598-019-46964-5 62. Zou ZH, Liu D, Li HD, et al. Prenatal and postnatal antibiotic exposure influences the gut microbiota of preterm infants in neonatal intensive care units. Ann Clin Microbiol Antimicrob . Mar 2018;17(1):9. doi:10.1186/s12941-018- 0264-y 63. Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed . Jan 2011;96(1):F9-F14. doi:10.1136/adc.2009.178798 64. Cohen-Wolkowiez M, Benjamin DK, Capparelli E. Immunotherapy in neonatal sepsis: advances in treatment and prophylaxis. Curr Opin Pediatr . Apr 2009;21(2):177-81. doi:10.1097/MOP.0b013e32832925e5 65. Escobar GJ, Puopolo KM, Wi S, et al. Stratification of risk of early-onset sepsis in newborns ≥ 34 weeks’ gestation. Pediatrics . Jan 2014;133(1):30-6. doi:10.1542/peds.2013-1689 66. Fjalstad JW, Stensvold HJ, Bergseng H, et al. Early-onset Sepsis and Antibiotic Exposure in Term Infants: A Nationwide Population-based Study in Norway. Pediatr Infect Dis J . Jan 2016;35(1):1-6. doi:10.1097/INF.0000000000000906 67. Cantey JB, Huffman LW, Subramanian A, et al. Antibiotic Exposure and Risk for Death or Bronchopulmonary Dysplasia in Very Low Birth Weight Infants. J Pediatr . 02 2017;181:289-293.e1. doi:10.1016/j.jpeds.2016.11.002 68. van den Anker J, Allegaert K. Rational Use of Antibiotics in Neonates: Still in Search of Tailored Tools. Healthcare (Basel) . Feb 2019;7(1)doi:10.3390/healthcare7010028 69. Bailey LC, Forrest CB, Zhang P, Richards TM, Livshits A, DeRusso PA. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr . Nov 2014;168(11):1063-9. doi:10.1001/jamapediatrics.2014.1539